Patent · US Active

Use of histones for therapeutic purposes

US8962562B2 · kind B2 · utility

0Cited by

7References

11Claims

0Family size

Assignee

Lipoxen Technologies Limited · GB

Inventors

Reiner Class · Drexel Hill, US
Michael Zeppezauer · Scheidt, DE

Key dates

Filing date	Feb 4, 2013
Grant date	Feb 24, 2015
Priority date	—
Expiry date	Feb 4, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of at least one human recombinant histone, especially at least one histone H1 subtype, and/or a therapeutic histone fraction as a basis for the treatment of thrombocytopenia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.